|
|
Article Cited by others ORIGINAL ARTICLE
Clinical and familial correlates of tardive dyskinesia in India and Israel
Bhatia T, Sabeeha M R, Shriharsh V, Garg K, Segman R H, Uriel H L, Strous R, Nimgaonkar V L, Bernard L, Deshpande Smita N
Year : 2004| Volume: 50| Issue : 3 | Page no: 167-172 This article has been cited by | 1 |
White matter abnormalities in schizophrenia patients with tardive dyskinesia: A diffusion tensor image study |
|
| | Bai, Y.M., Chou, K.-H., Lin, C.-P., Chen, I.-Y., Li, C.-T., Yang, K.C., Chou, Y.-H., Su, T.-P. | | | Schizophrenia Research. 2009; 109((1-3)): 167-181 | | | [Pubmed] [Google Scholar] | | 2 |
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression |
|
| | Ormerod S, McDowell SE, Coleman JJ, et al. | | | DRUG SAFETY. 2008; 31(7): 597-607 | | | [Pubmed] [Google Scholar] | | 3 |
Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics |
|
| | Thelma BK, Srivastava V, Tiwari AK | | | PHARMACOGENOMICS. 2008; 9(9): 1285-1306 | | | [Pubmed] [Google Scholar] | | 4 |
Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population |
|
| | Boke, O., Gunes, S., Kara, N., Aker, S., Sahin, A.R., Basar, Y., Bagci, H. | | | DNA and Cell Biology. 2007; 26(8): 527-531 | | | [Pubmed] [Google Scholar] | | 5 |
Use of antipsychotics and tardive dyskinesia |
|
| | Thara, R. | | | Journal of Postgraduate Medicine. 2004; 50(3): 172 | | | [Pubmed] [Google Scholar] | |
|
|